Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Generic Companies Race To Withdraw ANDAs
Jul 08 2019
•
By
Derrick Gingery
After 606 ANDAs were removed in FY 2018, another 252 have been pulled in FY 2019, many of them approved applications. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics